WHO recommendation on the use of intrauterine balloon tamponade for the treatment of postpartum haemorrhage

WHO recommendation on the use of intrauterine balloon tamponade for the treatment of postpartum haemorrhage


If women do not respond to treatment using uterotonics, or if uterotonics are unavailable, the use of intrauterine balloon tamponade is recommended for the treatment of PPH due to uterine atony.

(Weak recommendation, very-low-quality evidence)


Publication history

First published: September 2012

Updated: No update planned

Assessed as up-to-date: September 2012



  • The GDG noted that the use of manoeuvres and other procedures requires training and that maternal discomfort and complications associated with these procedures have been reported.
  • The use of balloon tamponade was considered by the GDG to be a measure that can potentially avoid surgery or as a temporizing measure while awaiting transfer to a higher level facility. The GDG acknowledges that balloon tamponade can be obtained with specific devices as well as with lower cost adaptations, including those based on the use of condoms and surgical gloves.



Postpartum haemorrhage (PPH) is defined as blood loss of 500ml or more within 24 hours after birth. PPH is the primary cause of nearly one-fifth of all maternal deaths globally. Most of these deaths occur during the first 24 hours after birth. The majority could be prevented through the use of prophylactic uterotonics during the third stage of labour, and by timely and appropriate management.

The use of intrauterine balloon tamponade can potentially avoid surgery or could be used as a temporizing measure while awaiting transfer to a higher level facility.   



The recommendation was developed using standardized operating procedures in accordance with the process described in the “WHO handbook for guideline development”, based on the GRADE approach (1, 2) Outcomes used for this recommendation were the prioritized outcomes from the WHO recommendations on prevention and treatment of postpartum haemorrhage (2012).(3)

No randomized controlled trials have examined the use of uterine tamponade for the treatment of PPH. Evidence from case series and case reports was evaluated. Data on relevant outcomes and comparisons were extracted.

WHO convened a Guideline Development Group (GDG) meeting in March 2012. This group of independent experts used the evidence profiles to assess evidence on effects on the pre-specified outcomes. GDG members discussed the balance between desirable and undesirable effects, overall quality of supporting evidence, values and preferences, magnitude of effect, balance of benefits versus disadvantages, resource usage, and feasibility, to formulate the recommendation. Remarks were added to clarify the recommendation, and aid implementation.

Further information on procedures for developing this recommendation are available here.


Recommendation question

For this recommendation, we aimed to answer the following question:

  • For women with postpartum haemorrhage (P), does intrauterine balloon tamponade (I) compared to placebo or no treatment (C) improve outcomes (O)?


Evidence summary

No RCTs were identified on the use of uterine tamponade for the treatment of PPH. Twenty-two case series and 18 case reports were identified (278 women), as well as two reviews. The instruments used included Sengstaken-Blakemore and Foley catheters, Bakri and Rusch balloons, and condoms. Case series have reported success rates (indicating that there was no use of hysterectomy or other invasive procedures) that ranged from 60 % to 100 %.

Further information on evidence supporting this recommendation are available here.


Implementation considerations

  • The successful introduction of evidence-based policies related to the prevention and management of PPH into national programmes and health care services depends on well-planned and participatory consensus-driven processes of adaptation and implementation. These processes may include the development or revision of national guidelines or protocols based on this recommendation.
  • The recommendation should be adapted into locally-appropriate documents and tools that are able to meet the specific needs of each country and health service. Modifications to the recommendation, where necessary, should be justified in an explicit and transparent manner.
  • An enabling environment should be created for the use of this recommendation, including changes in the behaviour of health care practitioners to enable the use of evidence-based practices.
  • Local professional societies may play important roles in this process and an all-inclusive and participatory process should be encouraged.


Related links

WHO recommendations on prevention and treatment of postpartum haemorrhage (2012) - full documentand evidence tables

Managing Complications in Pregnancy and Childbirth: A guide for midwives and doctors

Pregnancy, Childbirth, Postpartum and Newborn Care: A guide for essential practice


Related resources

VIDEO: Active management of third stage of labour

Education material for teachers of midwifery. Managing postpartum haemorrhage.


Research implications

The GDG did not identify any research priorities related to this recommendation.



  1. WHO Handbook for Guideline Development (second edition). Geneva: World Health Organization; 2014.
  2. Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401-6. Epub 2011/01/05. doi: 10.1016/j.jclinepi.2010.07.015. PubMed PMID: 21208779.
  3. WHO recommendations for the prevention and treatment of postpartum haemorrhage. Geneva: World Health Organization, 2012.
  4. Diemert A, Ortmeyer G, Hollwitz B, Lotz M, Somville T, Glosemeyer P, et al. The combination of intrauterine balloon tamponade and the B-Lynch procedure for the treatment of severe postpartum hemorrhage. Am J Obstet Gynecol. 2011 Jan;206(1):65 e1-4.
  5. Khalil MI, Al-Dohami H, Aldahish MM. A method to improve the effectiveness of the Bakri balloon for management of postpartum hemorrhage at cesarean. Int J Gynaecol Obstet. Nov;115(2):198-200.
  6. Ishii T, Sawada K, Koyama S, Isobe A, Wakabayashi A, Takiuchi T, et al. Balloon tamponade during cesarean section is useful for severe post-partum hemorrhage due to placenta previa. J Obstet Gynaecol Res. Jan;38(1):102-7.
  7. Albayrak M, Ozdemir I, Koc O, Demiraran Y. Post-partum haemorrhage from the lower uterine segment secondary to placenta praevia/accreta: successful conservative management with Foley balloon tamponade. Aust N Z J Obstet Gynaecol. Aug;51(4):377-80.
  8. Raynal P. Bakri balloon. Gynecol Obstet Fertil. Jul-Aug;39(7-8):438-41.
  9. Yoong W, Ridout A, Memtsa M, Stavroulis A, Aref-Adib M, Ramsay-Marcelle Z, et al. Application of uterine compression suture in association with intrauterine balloon tamponade ('uterine sandwich') for postpartum hemorrhage. Acta Obstet Gynecol Scand. Jan;91(1):147-51.
  10. Sheikh L, Najmi N, Khalid U, Saleem T. Evaluation of compliance and outcomes of a management protocol for massive postpartum hemorrhage at a tertiary care hospital in Pakistan. BMC Pregnancy Childbirth.11:28.
  11. Kayem G, Kurinczuk JJ, Alfirevic Z, Spark P, Brocklehurst P, Knight M. Specific second-line therapies for postpartum haemorrhage: a national cohort study. BJOG.
  12. Jun;118(7):856-64.
  13. Ahonen J, Stefanovic V, Lassila R. Management of post-partum haemorrhage. Acta Anaesthesiol Scand. Nov;54(10):1164-78.
  14. Majumdar A, Saleh S, Davis M, Hassan I, Thompson PJ. Use of balloon catheter tamponade for massive postpartum haemorrhage. J Obstet Gynaecol.30(6):586-93.
  15. Sleth JC. Postpartum haemorrhage and uterine balloon: time to revise the French guidelines? Ann Fr Anesth Reanim. Jul-Aug;29(7-8):596-7.
  16. Thapa K, Malla B, Pandey S, Amatya S. Intrauterine condom tamponade in management of post partum haemorrhage. J Nepal Health Res Counc. Apr;8(1):19-22.
  17. Porreco RP, Stettler RW. Surgical remedies for postpartum hemorrhage. Clin Obstet Gynecol. Mar;53(1):182-95.
  18. Horng HC, Hu WM, Tseng HS, Chang WH, Chao KC, Yang MJ. Uterine arterial embolization in the management of severe post-partum hemorrhage: a successful rescue method to avoid peripartum hysterectomy. J Chin Med Assoc. Jun;74(6):25
  19. Simaika YS. The 'trio' condom catheter: a modification of the condom catheter in the management of postpartum haemorrhage. BJOG. Feb;117(3):372.
  20. Arduini M, Epicoco G, Clerici G, Bottaccioli E, Arena S, Affronti G. B-Lynch suture, intrauterine balloon, and endouterine hemostatic suture for the management of postpartum hemorrhage due to placenta previa accreta. Int J Gynaecol Obstet. Mar;108(3):191-3.
  21. Doumouchtsis SK, Papageorghiou AT. Managing massive postpartum haemorrhage. BJOG. 2009 Nov;116(12):1687-8.
  22. Vitthala S, Tsoumpou I, Anjum ZK, Aziz NA. Use of Bakri balloon in post-partum haemorrhage: a series of 15 cases. Aust N Z J Obstet Gynaecol. 2009 Apr;49(2):191-4.
  23. Georgiou C. Balloon tamponade in the management of postpartum haemorrhage: a review. BJOG. 2009 May;116(6):748-57.
  24. Doumouchtsis SK, Papageorghiou AT, Arulkumaran S. The surgical management of intractable postpartum hemorrhage. Acta Obstet Gynecol Scand. 2009;88(4):489-90; author reply 90-2.
  25. Lombaard H, Pattinson RC. Common errors and remedies in managing postpartum haemorrhage. Best Pract Res Clin Obstet Gynaecol. 2009 Jun;23(3):317-26.
  26. Moriarty T. Management of postpartum hemorrhage by uterine balloon tamponade. Acta Obstet Gynecol Scand. 2009;88(4):487; author reply -8.
  27. Doumouchtsis SK, Papageorghiou AT, Vernier C, Arulkumaran S. Management of postpartum hemorrhage by uterine balloon tamponade: prospective evaluation of effectiveness. Acta Obstet Gynecol Scand. 2008;87(8):849-55.
  28. Mousa HA, Cording V, Alfirevic Z. Risk factors and interventions associated with major primary postpartum hemorrhage unresponsive to first-line conventional therapy. Acta Obstet Gynecol Scand. 2008;87(6):652-61.
  29. Wise A, Clark V. Strategies to manage major obstetric haemorrhage. Curr Opin Anaesthesiol. 2008 Jun;21(3):281-7.
  30. Airede LR, Nnadi DC. The use of the condom-catheter for the treatment of postpartum haemorrhage - the Sokoto experience. Trop Doct. 2008 Apr;38(2):84-6.
  31. Dabelea V, Schultze PM, McDuffie RS, Jr. Intrauterine balloon tamponade in the management of postpartum hemorrhage. Am J Perinatol. 2007 Jun;24(6):359-64.
  32. Nelson WL, O'Brien JM. The uterine sandwich for persistent uterine atony: combining the B-Lynch compression suture and an intrauterine Bakri balloon. Am J Obstet Gynecol. 2007 May;196(5):e9-10.
  33. Bagga R, Jain V, Sharma S, Suri V. Postpartum hemorrhage in two women with impaired coagulation successfully managed with condom catheter tamponade. Indian J Med Sci. 2007 Mar;61(3):157-60.
  34. Keriakos R, Mukhopadhyay A. The use of the Rusch balloon for management of severe postpartum haemorrhage. J Obstet Gynaecol. 2006 May;26(4):335-8.
  35. Seror J, Allouche C, Elhaik S. Use of Sengstaken-Blakemore tube in massive postpartum hemorrhage: a series of 17 cases. Acta Obstet Gynecol Scand. 2005 Jul;84(7):660-4.
  36. Akhter S, Begum MR, Kabir Z, Rashid M, Laila TR, Zabeen F. Use of a condom to control massive postpartum hemorrhage. MedGenMed. 2003 Sep 11;5(3):38.
  37. Condous GS, Arulkumaran S, Symonds I, Chapman R, Sinha A, Razvi K. The "tamponade test" in the management of massive postpartum hemorrhage. Obstet Gynecol. 2003 Apr;101(4):767-72.
  38. Marcovici I, Scoccia B. Postpartum hemorrhage and intrauterine balloon tamponade. A report of three cases. J Reprod Med. 1999 Feb;44(2):122-6.
  39. Goldrath MH. Uterine tamponade for the control of acute uterine bleeding. Am J Obstet Gynecol. 1983 Dec 15;147(8):869-72.
  40. Doumouchtsis SK, Papageorghiou AT, Arulkumaran S. Systematic review of conservative management of postpartum hemorrhage: what to do when medical treatment fails. Obstet Gynecol Surv. 2007 Aug;62(8):540-7.
  41. Condous GS, Arulkumaran S. Medical and conservative surgical management of postpartum hemorrhage. J Obstet Gynaecol Can. 2003 Nov;25(11):931-6.


Citation: WHO Reproductive Health Library. WHO recommendation on the use of uterine tamponade for the treatment of postpartum haemorrhage (September 2012). The WHO Reproductive Health Library; Geneva: World Health Organization.